Abiomed gains German reimbursement approval for Impella Recover heart assist devices

By Ted A. Knutson

Washington, Feb. 3 - Abiomed, Inc. announced Friday that the governmental authority for reimbursement in Germany has granted the highest approval level available for Abiomed's Impella Recover heart assist devices.

The new German reimbursement standard will apply to Abiomed's Impella Recover LP 2.5, the Impella Recover 5.0, the Impella Recover RD and the Impella Recover LD, which are available in Europe under the CE Mark and are investigational in the United States.

Abiomed also announced it has recently received product registration approval in France and has now begun shipment of Impella technologies to customers in this country. Germany and France represent the largest circulatory assist markets in Europe.

Based in Danvers, Mass., Abiomed is a developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.